These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8993080)

  • 1. Pharmacologic treatment of body dysmorphic disorder.
    Phillips KA
    Psychopharmacol Bull; 1996; 32(4):597-605. PubMed ID: 8993080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
    Phillips KA; Dwight MM; McElroy SL
    J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.
    Phillips KA
    Psychopharmacol Bull; 1996; 32(1):175-80. PubMed ID: 8927669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
    Phillips KA; Albertini RS; Siniscalchi JM; Khan A; Robinson M
    J Clin Psychiatry; 2001 Sep; 62(9):721-7. PubMed ID: 11681769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body dysmorphic disorder: diagnosis and treatment of imagined ugliness.
    Phillips KA
    J Clin Psychiatry; 1996; 57 Suppl 8():61-4; discussion 65. PubMed ID: 8698683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of citalopram in body dysmorphic disorder.
    Phillips KA; Najjar F
    J Clin Psychiatry; 2003 Jun; 64(6):715-20. PubMed ID: 12823088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
    Hollander E; Allen A; Kwon J; Aronowitz B; Schmeidler J; Wong C; Simeon D
    Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
    Phillips KA; Hollander E
    Body Image; 2008 Mar; 5(1):13-27. PubMed ID: 18325859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of somatoform disorders.
    Fallon BA
    J Psychosom Res; 2004 Apr; 56(4):455-60. PubMed ID: 15094032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
    Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
    J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label study of escitalopram in body dysmorphic disorder.
    Phillips KA
    Int Clin Psychopharmacol; 2006 May; 21(3):177-9. PubMed ID: 16528140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.
    Phillips KA
    Am J Psychiatry; 2005 Feb; 162(2):377-9. PubMed ID: 15677604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body dysmorphic disorder and depression: theoretical considerations and treatment strategies.
    Phillips KA
    Psychiatr Q; 1999; 70(4):313-31. PubMed ID: 10587987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
    Phillips KA; Albertini RS; Rasmussen SA
    Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy and psychotherapy for body dysmorphic disorder.
    Ipser JC; Sander C; Stein DJ
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD005332. PubMed ID: 19160252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body dysmorphic disorder--a fear of imagined ugliness.
    Jefferys DE; Castle DJ
    Aust Fam Physician; 2003 Sep; 32(9):722-5. PubMed ID: 14524210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.
    Phillips KA; Pagano ME; Menard W
    Ann Clin Psychiatry; 2006; 18(4):251-7. PubMed ID: 17162625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognizing and treating body dysmorphic disorder.
    Grant JE; Phillips KA
    Ann Clin Psychiatry; 2005; 17(4):205-10. PubMed ID: 16402752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body dysmorphic disorder: diagnostic controversies and treatment challenges.
    Phillips KA
    Bull Menninger Clin; 2000; 64(1):18-35. PubMed ID: 10695157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder.
    Phillips KA; Kelly MM
    Focus (Am Psychiatr Publ); 2021 Oct; 19(4):413-419. PubMed ID: 35747292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.